The Hormel Institute, University of Minnesota shared a post on LinkedIn:
“Meet our Keynote Speaker for the upcoming Global Cancer Consortium International Conference at The Hormel Institute June 12-13:
Catherine Alix-Panabières is Professor of Oncology and Director of the Laboratory of Rare Human Circulating Cells and Liquid Biopsy (LCCRH) at Montpellier University Hospital and the Faculty of Medicine. Since 2022, she has also served as a Professor at the University of Hamburg, Germany.
A pioneer in circulating tumor cell (CTC) research for over 27 years, she co-introduced the term liquid biopsy in 2010 with Professor Klaus Pantel. Her landmark work demonstrated the clinical utility of CTCs in breast cancer. In 2020, Nature highlighted her contributions to liquid biopsy as a major cancer research breakthrough of the past two decades.
Learn more about our keynote and invited speakers, submit your abstract, and register for the conference.”
Other articles featuring Catherine Alix-Panabières on OncoDaily.